Porter Novelli NV

Tweet this page
No longer registered as of 13 May 2022 - Registration as it was on 16 Jun 2021
How to read and use this data card.
Download this datacard


Lobbying Costs


Financial year: Jan 2020 - Dec 2020

Lobbyists (Full time equivalent)

5.5 Fte (9)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info

    Porter Novelli NV

    EU Transparency Register

    140115237045-63 First registered on 21 Jan 2020

    Goals / Remit

    Porter Novelli is an award-winning, global purpose communications consultancy with more than 45 years’ experience and 100 offices across 60 countries. Our Brussels office is the main European hub for Porter Novelli’s international client work. With more than 25 multinational and multilingual communication professionals, we specialise in providing policy communications, public affairs, advocacy, strategic communications and reputation management services for our European and international clients. As a fully integrated global team, we offer the experience and expertise of our consultants worldwide.

    Main EU files targeted

    The client base of Porter Novelli Brussels includes companies, associations and not-for profit organisations. We advise organisations mainly from the Health & Life Sciences and Agriculture & Food sectors. We follow specific EU legislative proposals and/or policies varying according to the interests of our clients. The topics of interest include: Rare Diseases, Cancer, Biosimilars, Medicine Shortages, Supply Chains, Medicines Pricing and Quality, Pharmaceutical Strategy, Orphan Medicines Regulation, Clinical Trials, Data Policy, GDPR, Pharmacovigilance, Social Policy, Vaccines, Digital Health, Medical Devices, Nutrition Strategy, CAP Reform, Circular Economy, Food Safety and Food Quality, Green Deal related measures, Farm to Fork Strategy, Integrated Pest Management, Novel Foods, REACH, RoHS, Renewables Policy.


    Head Office
    Rue de l'Escaut 122
    Brussels 1080
  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories


    I - Professional consultancies/law firms/self-employed consultants


    Professional consultancies

  • Networking


    None declared

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2020 - Dec 2020

    Lobbying costs for closed financial year


    Other financial info

    None declared

    Declared lobby clients

    Client Name Amount
    Amgen 10,000€ - 24,999€
    BAYER PHARMA 50,000€ - 99,999€
    BIOGEN 0€ - 9,999€
    Bristol Myers Squibb 10,000€ - 24,999€
    Galapagos 0€ - 9,999€
    Incyte, 0-European Health Parliament (EHP) 50,000€ - 99,999€
    Kyowa Kirin International 100,000€ - 199,999€
    Pfizer 100,000€ - 199,999€
    Plasma Protein Therapeutics Association (PPTA) 10,000€ - 24,999€
    Takeda 200,000€ - 299,999€
    The European Federation of Pharmaceutical Industries and Associations (EFPIA) 25,000€ - 49,999€
    World Bladder Cancer Patient Coalition (WBCPC) 50,000€ - 99,999€
  • EU Structures

    Groups (European Commission)


    Groups (European Parliament)


    Communication activities


    Other activities

    None declared

  • Meetings


    None declared

Download this datacard